| # | Drug | Count |
|---|---|---|
| 0 | PATIROMER | 15 |
| 1 | AMBRISENTAN | 11 |
| 2 | MACITENTAN | 10 |
| 3 | TADALAFIL | 8 |
| 4 | ASPIRIN | 7 |
| 5 | FUROSEMIDE | 7 |
| 6 | SILDENAFIL CITRATE | 7 |
| 7 | TREPROSTINIL | 7 |
| 8 | ALLOPURINOL | 6 |
| 9 | ASPIRIN 325 MG | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM POLYSTYRENE SULFONATE | 3 | 0.0019 |
| 1 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 2 | PATIROMER | 15 | 0.0011 |
| 3 | PSYLLIUM HUSK | 1 | 0.0007 |
| 4 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 1 | 0.0007 |
| 5 | CALCIFEDIOL | 1 | 0.0004 |
| 6 | HYDRALAZINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | SEVELAMER CARBONATE | 4 | 0.0003 |
| 8 | VUTRISIRAN | 1 | 0.0003 |
| 9 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Potassium Binder [EPC] | 16 | 0.0011 |
| 1 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 2 | Soluble Guanylate Cyclase Stimulator [EPC] | 6 | 0.0002 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 6 | 0.0001 |
| 9 | Insulin [EPC] | 5 | 0.0001 |